Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
ACTION ON COVID-19
NCT04604184Phase 2Terminated
- Sponsor
- Boehringer Ingelheim
- Start
- Nov 2020
- Primary completion
- Mar 2021
- Modality
- Small Molecules
- Countries
- 6
01
Overview
A Phase 2 trial of apecotrep in coronavirus disease 2019 (COVID-19), acute respiratory distress syndrome (ARDS), sponsored by Boehringer Ingelheim. Started Nov 2020; status: terminated.
02
Drugs
apecotrep
03
Conditions
coronavirus disease 2019 (COVID-19)acute respiratory distress syndrome (ARDS)
Beyond the preview
Go deeper on NCT04604184.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT04604184.